XML 115 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair value measurements
12 Months Ended
Dec. 31, 2012
Fair Value Disclosures [Abstract]  
Fair value measurements
Fair Value Measurements
The Company measures its investments in certain fixed-income and equity securities at fair value with changes in fair value recognized in income. The Company anticipates using these investments, which consist of an insurance investment contract, to satisfy its obligations under its unfunded, nonqualified benefit plans for executive officers and certain key management employees, and invests in these fixed-income and equity securities for the purpose of earning investment returns and capital appreciation. These investments, which totaled $48.9 million and $38.4 million as of December 31, 2012 and 2011, respectively, are classified as Investments on the Consolidated Balance Sheets. The net unrealized gains on these investments for the years ended December 31, 2012 and 2010, were $5.2 million and $5.8 million, respectively. The net unrealized loss on these investments for the year ended December 31, 2011, was $1.1 million. The change in fair value, which is considered part of the cost of the plan, is classified in operation and maintenance expense on the Consolidated Statements of Income.

The Company did not elect the fair value option, which records gains and losses in income, for its remaining available-for-sale securities, which include auction rate securities, mortgage-backed securities and U.S. Treasury securities. These available-for-sale securities are recorded at fair value and are classified as Investments on the Consolidated Balance Sheets. The Company's auction rate securities approximated cost and, as a result, there were no accumulated unrealized gains or losses recorded in accumulated other comprehensive income (loss) on the Consolidated Balance Sheets related to these investments. In the second quarter of 2012, the Company sold its auction rate securities at cost and did not realize any gains or losses. Unrealized gains or losses on mortgage-backed securities and U.S. Treasury securities are recorded in accumulated other comprehensive income (loss). Details of available-for-sale securities were as follows:

December 31, 2012
Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value

 
(In thousands)
Insurance investment contract
$
37,250

$
11,648

$

$
48,898

Mortgage-backed securities
8,054

144

(3
)
8,195

U.S. Treasury securities
1,763

43


1,806

Total
$
47,067

$
11,835

$
(3
)
$
58,899



December 31, 2011
Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value

 
(In thousands)
Insurance investment contract
$
31,884

$
6,468

$

$
38,352

Auction rate securities
11,400



11,400

Mortgage-backed securities
8,206

95

(5
)
8,296

U.S. Treasury securities
1,619

37


1,656

Total
$
53,109

$
6,600

$
(5
)
$
59,704



The fair value of the Company's money market funds approximates cost.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The ASC establishes a hierarchy for grouping assets and liabilities, based on the significance of inputs.

The estimated fair values of the Company's assets and liabilities measured on a recurring basis are determined using the market approach.

The Company's Level 2 money market funds consist of investments in short-term unsecured promissory notes and the value is based on comparable market transactions taking into consideration the credit quality of the issuer. The estimated fair value of the Company's Level 2 mortgage-backed securities and U.S. Treasury securities are based on comparable market transactions, other observable inputs or other sources, including pricing from outside sources.

The estimated fair value of the Company's Level 2 insurance investment contract is based on contractual cash surrender values that are determined primarily by investments in managed separate accounts of the insurer. These amounts approximate fair value. The managed separate accounts are valued based on other observable inputs or corroborated market data.

The estimated fair value of the Company's Level 2 commodity derivative instruments is based upon futures prices, volatility and time to maturity, among other things. Counterparty statements are utilized to determine the value of the commodity derivative instruments and are reviewed and corroborated using various methodologies and significant observable inputs. The Company's and the counterparties nonperformance risk is also evaluated.

The estimated fair value of the Company's Level 2 interest rate derivative instruments is measured using quoted market prices or pricing models using prevailing market interest rates as of the measurement date. Counterparty statements are utilized to determine the value of the interest rate derivative instruments and are reviewed and corroborated using various methodologies and significant observable inputs. The Company's and the counterparties nonperformance risk is evaluated.

Though the Company believes the methods used to estimate fair value are consistent with those used by other market participants, the use of other methods or assumptions could result in a different estimate of fair value. For the years ended December 31, 2012 and 2011, there were no transfers between Levels 1 and 2.

The Company's assets and liabilities measured at fair value on a recurring basis are as follows:

 
Fair Value Measurements
at December 31, 2012, Using
 
 
Quoted Prices in Active Markets for Identical Assets (Level 1)

Significant Other Observable Inputs (Level 2)

Significant Unobservable Inputs
 (Level 3)

Balance at December 31, 2012

 
(In thousands)
Assets:
 
 
 
 
Money market funds
$

$
24,240

$

$
24,240

Available-for-sale securities:
 

 

 

 

Insurance investment contract*

48,898


48,898

Mortgage-backed securities

8,195


8,195

U.S. Treasury securities

1,806


1,806

Commodity derivative instruments

18,304


18,304

Total assets measured at fair value
$

$
101,443

$

$
101,443

Liabilities:
 

 

 

 

Interest rate derivative instruments
$

$
6,255

$

$
6,255

Total liabilities measured at fair value
$

$
6,255

$

$
6,255

* The insurance investment contract invests approximately 28 percent in common stock of mid-cap companies, 28 percent in common stock of small-cap companies, 29 percent in common stock of large-cap companies and 15 percent in fixed-income and other investments.


 
Fair Value Measurements
at December 31, 2011, Using
 
 
Quoted Prices in Active Markets for Identical Assets
 (Level 1)

Significant Other Observable Inputs (Level 2)

Significant Unobservable Inputs
 (Level 3)

Balance at December 31, 2011

 
(In thousands)
Assets:
 
 
 
 
Money market funds
$

$
97,500

$

$
97,500

Available-for-sale securities:
 
 
 
 
Insurance investment contract*

38,352


38,352

Auction rate securities

11,400


11,400

Mortgage-backed securities

8,296


8,296

U.S. Treasury securities

1,656


1,656

Commodity derivative instruments

30,455


30,455

Total assets measured at fair value
$

$
187,659

$

$
187,659

Liabilities:
 

 

 

 

Commodity derivative instruments
$

$
14,101

$

$
14,101

Interest rate derivative instruments

4,762


4,762

Total liabilities measured at fair value
$

$
18,863

$

$
18,863

* The insurance investment contract invests approximately 33 percent in common stock of mid-cap companies, 34 percent in common stock of small-cap companies, 32 percent in common stock of large-cap companies and 1 percent in cash and cash equivalents.


The Company's long-term debt is not measured at fair value on the Consolidated Balance Sheets and the fair value is being provided for disclosure purposes only. The fair value was based on discounted future cash flows using current market interest rates. The estimated fair value of the Company's Level 2 long-term debt at December 31 was as follows:

 
2012
2011
 
Carrying Amount

Fair Value

Carrying Amount

Fair Value

 
(In thousands)
Long-term debt
$
1,744,975

$
1,888,135

$
1,424,678

$
1,592,807



The carrying amounts of the Company's remaining financial instruments included in current assets and current liabilities approximate their fair values.